Understand the distinctions between the Nifty 50 and the Nifty BeES: The Nifty 50 is one of the two key indices in the Indian stock market that represent the economy's overall performance. Benchmark Asset Management launched the Nifty BeES ETF, which is based on this index.
In this article, we will compare the Nifty 50 to the Nifty BeES and look at the differences between the two.
What exactly is the Nifty 50?
The term "Nifty" is a combination of the words "National" and "Fifty." It is an index that serves as the National Stock Exchange's benchmark. It consists of the top 50 companies on the Indian stock exchange. What exactly are Nifty BeES?
Nifty BeES is an exchange-traded fund (ETF) that is a basket of securities that reflects the Nifty 50 Index's composition. This ETF is traded on the stock exchange and can be purchased and sold just like any other stock.
Nifty BeES tracks the Nifty 50 index and provides returns that are comparable to the Nifty 50 index. It trades at one-hundredth the value of the Nifty 50 index, allowing individuals to diversify their investments at a low cost. Read more on: Understand the distinctions between the Nifty 50 and the Nifty BeES
Căutare
Sponsor
Share this page
Categorii
- Whats New
- Shopping
- Wellness
- Sports
- Theater
- Religion
- Party
- Networking
- Music
- Literature
- Art
- Health
- Jocuri
- Food
- Drinks
- Fitness
- Gardening
- Dance
- Causes
- Film
- Crafts
- Other/General
- Cricket
- Grooming
- Technology
Citeste mai mult
Future COVID-19 Trends Tea Pods and Capsules Market Future Innovation Industry Trends and Forecast
To get success in this competitive market place, businesses consider taking up innovative...
Get Great Grades With Risk Management Assignment Help
We provide premium assistance for risk management assignment writing to relieve all the stress...
Black Horse Vital Honey Price in Peshawar | 03055997199 | (10g of 24 Pcs)
Black Horse Vital Honey - Shopping Online Ebaytelemart.pk
Manufacturer of a wide range of...
Data Bridge Market Research analyses that the Epstein-Barr virus drug will exhibit a CAGR of around 4.00% for the forecast period of 2021-2028.
Epstein-Barr Virus Drug Market report has been prepared by considering several fragments of the...